Omada Health, Inc. OMDA 深 滬
等待開盤 04-02 09:30:00 美东时间
12.61
+0.040
+0.32%
華盛通- 最 高13.25
- 今 開12.67
- 成交量 66.07万股
- 最 低 12.46
- 昨 收 12.57
- 總市值 7.43亿
- 52周最高 28.40
- 市盈率 靜 --
- 換手率 1.12%
- 52周最低 10.28
- 委 比 -84.45%
- 總股本 5892.54万
- 歷史最高 28.40
- 量 比 0.71
- 振 幅 6.28%
- 歷史最低 10.28
- 每 手 1
- 風險率 4.06%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅101%！甲骨文获花旗升目标价至320美元，维持"买入"评级
今日重点评级关注：Freedom Capital Markets：维持LifeMD"买入"评级，目标价从8美元升至10美元；Chardan Capital：维持Opus Genetics"买入"评级，目标价从9美元升至11美元
03-13 09:59
JP Morgan Maintains Overweight on Omada Health, Lowers Price Target to $26
JP Morgan analyst Destiny Jackson maintains Omada Health (NASDAQ:OMDA) with a Overweight and lowers the price target from $32 to $26.
03-13 02:58
美股大行评级 | 潜在涨幅183%！迈威尔科技获10家机构上调目标价最高至164美元；伯灵顿百货、好市多、Ciena、Samsara等获多家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持BridgeBio Oncology"买入"评级，目标价从27美元升至29美元；韦德布什：维持WAVE Life Sciences"跑赢大市"评级，目标价从33美元升至35美元
03-09 11:47
Why Is Omada Health Stock Soaring Friday?
Omada Health (OMDA) shares surge after beating Q4 earnings and launching the GLP-1 Flex Care program for employers. Read the full report.
03-06 21:34
Earnings Scheduled For March 5, 2026
Companies Reporting Before The Bell • Palladyne AI (NASDAQ:PDYN) is projected t...
03-05 19:11
美股大行评级 | 绩后暴跌超22%，MongoDB遭14家大行集团下调目标价；挪威邮轮、阿莎娜、Quantum Computing等也遭大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持NRX Pharmaceuticals"买入"评级，目标价从40美元升至45美元；RBC Capital：维持NUVATION BIO"跑赢大市"评级，目标价从12美元升至13美元
03-04 10:22
Barclays Maintains Overweight on Omada Health, Lowers Price Target to $17
Barclays analyst Saket Kalia maintains Omada Health (NASDAQ:OMDA) with a Overweight and lowers the price target from $22 to $17.
03-03 23:55
美股大行评级 | 潜在涨幅258.31%！Tempest Therapeutics获HC Wainwright上调评级至"买入"，目标价11美元
今日重点评级关注：HC Wainwright & Co.：上调Tempest Therapeutics评级至"买入"，目标价11美元；Guggenheim：维持Sportradar Gr"买入"评级，目标价从34美元升至35美元
01-23 19:46
Needham Reiterates Buy on Omada Health, Maintains $28 Price Target
Needham analyst Ryan MacDonald reiterates Omada Health (NASDAQ:OMDA) with a Buy and maintains $28 price target.
01-22 20:27
Omada Health Reports Preliminary Q4 2025 Revenue Of $72M-$74M; FY25 Revenue Of $256M-$258M; Total Members Reach ~886,000, Up 55% YoY
Omada Health (NASDAQ:OMDA), the virtual between-visit healthcare provider, today announced preliminary, unaudited revenue for the fourth quarter and fiscal year ended December 31, 2025, ahead of its presentation at the
01-12 22:12
